Generics 34

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Brivaracetam manufacturers

34 products found

Filters

34 products found

brivaracetam

Tablets 10 mg, 25 mg, 50 mg, 75 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Available for
Distribution only
Comments
Ref. Briviact
Manufacturer #269

A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 2 days

brivaracetam

Oral solution 10 mg/ml - 300 ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Comments
CTD with BE with Briviact
Manufacturer #10620

A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, the Middle East, North America, LATAM, and Asia for 50+ years. The main therapeutic areas include cardiovascular, rheumatology, nephrology, and central nervous system. The main dosage forms are oral solid and multi-dose powder. They are produced in GMP-compliant manufacture.

Manufacturer usually replies in 5 days

brivaracetam

Tablets, film coated 10 mg, 25 mg, 50 mg, 75 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Briviact®
Manufacturer #252
This company is a leading player in the pharmaceutical industry, boasting decades of experience in research, development, and manufacturing. They specialize in the production of a wide range of pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for both human and veterinary use. Their product portfolio spans multiple therapeutic areas, including but not limited to, oncology, cardiology, and other essential therapeutic categories. They offer a comprehensive range of services, including contract manufacturing (CMO) and the production of over-the-counter (OTC) products. The company holds EU and US GMP approvals for its production lines, ensuring adherence to rigorous quality standards. Their production lines encompass various dosage forms, including solids, liquids, and injectables. Their global presence extends across Europe and North America, with a network of 10 manufacturing facilities. They have a strong commitment to research and development, with dedicated teams focusing on innovative solutions and advancements in the pharmaceutical field.

Manufacturer usually replies in 12 days

Want to see all 34 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible